In an article titled “Hybrid revascularization remains relatively rare bird” (published March 6, 2015) Dr. Vinod H. Thourani wishes to clarify that, as he stated in his presentation, the current work he reported on from Emory University was performed by Dr. Michael Halkos, who is the leader of hybrid revascularization at Emory, and that Dr. Halkos was lead author and researcher in several of the other studies reported upon.

Ads

You May Also Like

Jury still out on mortality benefits of knee replacement in OA

FROM ANNALS OF THE RHEUMATIC DISEASES People with osteoarthritis who go on to have ...

HIV research update: Late December 2016

A great volume of HIV and AIDS research enters the medical literature every month. ...

CDC: Cancer incidence and survival improve; racial disparities persist

FROM MORBIDITY AND MORTALITY WEEKLY REPORT Numerous states have achieved Healthy People 2020 goals ...